- New immunotherapy research New research from our Immunotherapy group marks an important step forward in pioneering cell therapies that can treat blood cancer.…
- Summary An important statement from a major stem cell transplant organisation will help collection centres use a beneficial drug that aids stem cell collection…
- CAR-T for lupus CAR-T is a cell therapy that has made waves in the treatment of some blood cancers. It harnesses the natural capacity of important immune cells called T…
- Below are some key facts and statistics that you might find useful. For more information, contact us on press@anthonynolan.org or 0207 424 1300. What…
- New findings from Patient/Donor project New findings from Anthony Nolan’s flagship Patient/Donor project have shown that sometimes a perfect match isn’t always…
- New research from leading charity Anthony Nolan could pave the way for a change in how stem cell donors are selected and save the lives of more people with blood cancer and blood…
- Today, in a world first, blood cancer charity Anthony Nolan has launched new technology which will improve stem cell transplant outcomes and make the best patient-donor matches…
- A research breakthrough by scientists at the blood cancer charity Anthony Nolan could lead to better outcomes for patients having stem cell transplants using umbilical cord blood…
- Proteins found in umbilical cord blood could be used to treat eczema and rheumatoid arthritis, some surprising new findings by our researchers suggest. Scientists at the Anthony…
- Research by blood cancer charity Anthony Nolan shows new tissue typing method could ‘revolutionise’ the field of stem cell transplantation New technology could ‘significantly’…